Expect significant downward pressure on VNRX shares as the market prices in the ~34% dilution and the company's precarious financial position. Watch for the actual closing size — if the full $4.1M is raised, the immediate cash runway extension is modest, but the signal of distress (going concern + dilutive financing) is strongly bearish. Monitor for any future convertible note conversions or further equity raises given the heavy overhang.
Price Chart
Executive Summary
VolitionRx is conducting a best-efforts offering of up to 2,960,000 shares of common stock and warrants to purchase up to 1,480,000 shares at a combined price of $1.55 per unit, targeting ~$4.1M net proceeds. The company has a going-concern opinion from its auditors, negative tangible book value of -$33.7M, and existing convertible notes (Lind Notes) that constitute heavy overhang. The offering is severely dilutive (34% dilution on current shares), and proceeds are needed for operations and debt repayment—a clear distress signal for the micro-cap diagnostics company.
Key Facts
- Offering of 2,960,000 shares + warrants for 1,480,000 shares at $1.55/unit, gross proceeds of $4.588M, net ~$4.1M
- Combined public offering price of $1.55 is an 11.5% premium to the $1.39 closing price on June 8, 2026
- Pro forma dilution: from 8,627,191 shares outstanding to over 11.6M shares (34% increase)
- Immediate dilution of $4.265 per share to new investors vs negative tangible book value of -$33.7M as of March 31, 2026
- Auditors have expressed substantial doubt about the company's ability to continue as a going concern
- Proceeds will be used for R&D, working capital, and repayment of Lind Notes (secured convertible notes totaling $9.9M principal)
- Convertible notes with $1.891/share conversion price and heavy warrant overhang (~7M+ shares issuable from existing instruments)
- Best-efforts offering with no minimum — may raise less than $4.1M
- Reverse stock split (1:20) was just effected in April 2026 to maintain NYSE American listing
Financial Impact
34% dilution on current outstanding shares from the base offering alone; additional 1.48M shares issuable upon warrant exercise; net proceeds of ~$4.1M equate to ~34% of the $12M market cap
Risk Factors
- Going concern risk — auditors expressed substantial doubt about ability to continue operating
- Severe dilution from this offering and existing convertible notes/warrants
- Best-efforts offering may raise less than targeted amount, leaving the company undercapitalized
- Heavy debt load via Lind Notes ($9.9M combined principal) secured by company assets
- Negative tangible book value of -$33.7M indicates negative equity on a tangible basis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001477932-26-003713 |
| Document: 0001477932-26-003713-index-headers.html | 0001477932-26-003713 |
| Document: 0001477932-26-003713-index.html | 0001477932-26-003713 |
| Document: 0001477932-26-003713.txt | 0001477932-26-003713 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $0.2529 | awaiting T+60 | — | $0.1800 (+28.83%) |
Sep 16, 2026 5w ago | SC 13D/A | $0.2849 | awaiting T+60 | — | $0.1800 (−36.82%) |
Sep 15, 2026 5w ago | 8-K | $0.2749 | awaiting T+60 | — | $0.1800 (+34.52%) |
Sep 11, 2026 6w ago | EFFECT | $0.3102 | awaiting T+60 | — | $0.1800 (+41.97%) |
Sep 8, 2026 6w ago | S-3/A | $0.3400 | awaiting T+60 | — | $0.1800 (+47.06%) |
Sep 1, 2026 7w ago | 8-K | $0.3800 | awaiting T+60 | — | $0.1800 (+52.63%) |
Aug 24, 2026 9w ago | 8-K | $0.3846 | awaiting T+60 | — | $0.1800 (+53.20%) |
Aug 7, 2026 11w ago | 8-K | $0.7700 | awaiting T+60 | — | $0.1800 (+76.62%) |
Jul 20, 2026 14w ago | EFFECT | $1.13 $0.1847 | ▲ +83.65% | ▲ +88.50% | $0.1800 (+84.07%) |
Jun 18, 2026 18w ago | 8-K | $1.34 | awaiting T+60 | — | $0.1800 (+86.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers